<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03625700</url>
  </required_header>
  <id_info>
    <org_study_id>OxyEWS2018</org_study_id>
    <nct_id>NCT03625700</nct_id>
  </id_info>
  <brief_title>Supplementary Oxygen in Surgical and Medical Wards Evaluated by 30-day Mortality</brief_title>
  <acronym>SOSAM</acronym>
  <official_title>Supplementary Oxygen in Surgical and Medical Wards in the Capital Region of Denmark Evaluated by 30-day Mortality, a Retrospective Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hannibal Troensegaard</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Bispebjerg and Frederiksberg</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the use and effects of supplementary oxygen in surgical and medical&#xD;
      wards on patients admitted to a hospital in the capital region of Denmark. The population&#xD;
      will be divided in to three groups according to their oxygenation status. The main outcome&#xD;
      will be 30-day mortality, with secondary outcomes being Length of stay, 30-day admission to&#xD;
      ICU, 30-day reoperations, 30-day readmission, and peak values within 30-days of C-reactive&#xD;
      protein, S-Creatinine, Troponin.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2014</start_date>
  <completion_date type="Actual">December 2020</completion_date>
  <primary_completion_date type="Actual">August 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>30- day mortality</measure>
    <time_frame>30 days</time_frame>
    <description>Will be reported as a fraction of positives within the exposure group population</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of stay</measure>
    <time_frame>30 days</time_frame>
    <description>Length of hospital stay in days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Organ markers in blood samples</measure>
    <time_frame>30 days</time_frame>
    <description>Highest value of C-reactive protein, Troponin and Creatinine within 30 days.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>30- day admission to ICU</measure>
    <time_frame>30 days</time_frame>
    <description>Will be reported as a fraction of positives within the exposure group population.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>30- day readmission</measure>
    <time_frame>30 days</time_frame>
    <description>will be reported as a fraction of positives within the exposure group population.</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">11196</enrollment>
  <condition>Oxygen Toxicity</condition>
  <condition>Oxygen Deficiency</condition>
  <arm_group>
    <arm_group_label>Hypoxia</arm_group_label>
    <description>Patients without chronic obstructive pulmonary disease: blood oxygen saturation &lt;94 % irrespective of supplemental oxygen&#xD;
Patients with chronic obstructive pulmonary disease: blood oxygen saturation &lt;88% irrespective of supplemental oxygen</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normoxia</arm_group_label>
    <description>Patients without chronic obstructive pulmonary disease: blood oxygen saturation 94-98% in combination with supplemental oxygen OR blood oxygen saturation ≥94% without supplemental oxygen.&#xD;
Patients with chronic obstructive pulmonary disease: blood oxygen saturation 88-92% in combination with supplemental oxygen OR blood oxygen saturation ≥88% without supplemental oxygen.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hyperoxia</arm_group_label>
    <description>Patients without chronic obstructive pulmonary disease: blood oxygen saturation &gt;98% in combination with supplemental oxygen&#xD;
Patients with chronic obstructive pulmonary disease: blood oxygen saturation &gt;92% in combination with supplemental oxygen</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxygen gas</intervention_name>
    <description>Supplementary oxygen supplied via nasal catheter or oxygen mask during hospital admission.</description>
    <arm_group_label>Hyperoxia</arm_group_label>
    <arm_group_label>Hypoxia</arm_group_label>
    <arm_group_label>Normoxia</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study is made up of four main population groups, each group having their specific&#xD;
        vulnerabilities, thus making the main outcome (30-day mortality) more likely to occur than&#xD;
        in the background population.&#xD;
&#xD;
        The four groups are:&#xD;
&#xD;
          1. Patients undergoing laparotomy (open abdominal surgery)&#xD;
&#xD;
          2. Patients undergoing orthopedic surgery due to hip fracture&#xD;
&#xD;
          3. Patients admitted to hospital due to chronic obstructive pulmonary disease in&#xD;
             exacerbation&#xD;
&#xD;
          4. Patients admitted to hospital with acute mycardial infarction&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Admission date between 1st of January 2014 to 29th of December 2014 on a hospital in&#xD;
             the capital region of Denmark&#xD;
&#xD;
          -  Age ≥18&#xD;
&#xD;
          -  Unique (first) admission in database for either:&#xD;
&#xD;
          -  Hip fracture requiring surgery&#xD;
&#xD;
          -  Chronic obstructive pulmonary disease in exacerbation&#xD;
&#xD;
          -  Acute mycardial infarction&#xD;
&#xD;
          -  Open abdominal surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  No data on saturation within 48 hours after&#xD;
&#xD;
          -  Admission (Medical patients)&#xD;
&#xD;
          -  Discharge from the post anaesthesia care unit (Surgical patients)&#xD;
&#xD;
          -  No data on primary outcome (30-day mortality)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Bispebjerg og Frederiksberg Hospital</name>
      <address>
        <city>København</city>
        <state>NV</state>
        <zip>2400</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>July 10, 2018</study_first_submitted>
  <study_first_submitted_qc>August 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 10, 2018</study_first_posted>
  <last_update_submitted>January 10, 2021</last_update_submitted>
  <last_update_submitted_qc>January 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Bispebjerg and Frederiksberg</investigator_affiliation>
    <investigator_full_name>Hannibal Troensegaard</investigator_full_name>
    <investigator_title>Primary investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoxia</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>July 25, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/00/NCT03625700/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

